Your session is about to expire
← Back to Search
Counter-marketing messages for Obesity
N/A
Waitlist Available
Led By Anna H Grummon, PhD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up the survey will take up to 20 minutes
Awards & highlights
Study Summary
This trial will investigate how different messages about sugary drinks affect people's drinking habits & how age affects that reaction. #HealthResearch
Eligible Conditions
- Obesity
- Weight Bias
- Eating Habits
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ the survey will take up to 20 minutes
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~the survey will take up to 20 minutes
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Intentions to consume sugary drinks
Secondary outcome measures
Anticipated social interactions
Attitudes toward sugary drink companies
Message reactance
+3 moreTrial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Traditional health messagesExperimental Treatment1 Intervention
Participants will view traditional health messages focused on the health consequences of sugar-sweetened beverage consumption, using text adapted from prior sugary drink campaigns. Participants will view a total of 4 messages developed for this arm.
Group II: Counter-marketing messagesExperimental Treatment1 Intervention
Participants will view counter-marketing messages about sugary drinks that incorporate principles of effective counter-marketing campaigns, including describing industry manipulation of consumers, appealing to emotions (especially anger), describing health consequences, and criticizing the industry for demographic targeting. Messages include text adapted from prior counter-marketing campaigns. Participants will view a total of 4 messages developed for this arm.
Group III: Control (neutral) messagesActive Control1 Intervention
Participants will view control messages approximately matched to the intervention messages on length, but discussing a neutral topic unrelated to sugary drinks (safe driving). Participants will view a total of 4 messages developed for this arm.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Exposure to traditional health messages
2023
N/A
~2190
Exposure to counter-marketing messages
2023
N/A
~2190
Find a Location
Who is running the clinical trial?
Stanford UniversityLead Sponsor
2,387 Previous Clinical Trials
17,331,866 Total Patients Enrolled
69 Trials studying Obesity
268,052 Patients Enrolled for Obesity
Harvard Pilgrim Health CareOTHER
54 Previous Clinical Trials
27,778,794 Total Patients Enrolled
9 Trials studying Obesity
748,686 Patients Enrolled for Obesity
Anna H Grummon, PhDPrincipal InvestigatorStanford School of Medicine, Department of Pediatrics
3 Previous Clinical Trials
4,941 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is recruitment for this trial still open at the moment?
"Per the information provided on clinicaltrials.gov, this particular medical trial has reached its recruitment quota and is no longer accepting applications; it was initially posted on July 1st 2023 with a final update taking place ten days later. Nevertheless, 1149 alternate studies are currently seeking participants."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger